Patents Assigned to Women's College Hospital
  • OVARIAN CANCER BIOMARKER AND METHODS OF USING SAME
    Publication number: 20220390453
    Abstract: The present invention provides a novel ovarian cancer marker, Arresten, and related methods, agents, and kits using same. The invention includes methods for detecting or diagnosing ovarian cancer, especially at early stages of the disease. The invention also includes methods of assessing the severity of ovarian cancer and monitoring responses to treatment for ovarian cancer using the biomarker.
    Type: Application
    Filed: June 16, 2022
    Publication date: December 8, 2022
    Applicant: Women's College Hospital
    Inventor: Mohammad R. AKBARI
  • OVARIAN CANCER BIOMARKER AND METHODS OF USING SAME
    Publication number: 20210181200
    Abstract: The present invention provides a novel ovarian cancer marker, Arresten, and related methods, agents, and kits using same. The invention includes methods for detecting or diagnosing ovarian cancer, especially at early stages of the disease. The invention also includes methods of assessing the severity of ovarian cancer and monitoring responses to treatment for ovarian cancer using the biomarker.
    Type: Application
    Filed: December 14, 2020
    Publication date: June 17, 2021
    Applicant: Women's College Hospital
    Inventor: Mohammad R. AKBARI
  • Breast cancer biomarkers and methods of using same
    Patent number: 10131957
    Abstract: The present invention provides breast cancer markers based on RECQL mutations, and related methods, uses, agents, and kits. The invention includes methods for determining the susceptibility of a subject to developing breast cancer, and methods for detecting, diagnosing, treating, and predicting responses to treatment for breast cancer.
    Type: Grant
    Filed: November 30, 2017
    Date of Patent: November 20, 2018
    Assignee: Women's College Hospital
    Inventor: Mohammad R. Akbari
  • BREAST CANCER BIOMARKERS AND METHODS OF USING SAME
    Publication number: 20180163273
    Abstract: The present invention provides breast cancer markers based on RECQL mutations, and related methods, uses, agents, and kits. The invention includes methods for determining the susceptibility of a subject to developing breast cancer, and methods for detecting, diagnosing, treating, and predicting responses to treatment for breast cancer.
    Type: Application
    Filed: November 30, 2017
    Publication date: June 14, 2018
    Applicant: Women's College Hospital
    Inventor: Mohammad R. AKBARI
  • Breast cancer biomarkers and methods of using same
    Patent number: 9926607
    Abstract: The present invention provides breast cancer markers based on RECQL mutations, and related methods, uses, agents, and kits. The invention includes methods for determining the susceptibility of a subject to developing breast cancer, and methods for detecting, diagnosing, treating, and predicting responses to treatment for breast cancer.
    Type: Grant
    Filed: March 23, 2016
    Date of Patent: March 27, 2018
    Assignee: Women's College Hospital
    Inventor: Mohammad R. Akbari
  • BREAST CANCER BIOMARKERS AND METHODS OF USING SAME
    Publication number: 20160281173
    Abstract: The present invention provides breast cancer markers based on RECQL mutations, and related methods, uses, agents, and kits. The invention includes methods for determining the susceptibility of a subject to developing breast cancer, and methods for detecting, diagnosing, treating, and predicting responses to treatment for breast cancer.
    Type: Application
    Filed: March 23, 2016
    Publication date: September 29, 2016
    Applicant: Women's College Hospital
    Inventor: Mohammad R. AKBARI